Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype

Conference Object

Abstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholestero

Palabras claves:

Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, Triglycerides

Autores:

Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore Bermúdez

Fuentes:

scopus